Hasil Pencarian - Marcus A Horwitz
- Menampilkan 1 - 14 hasil dari 14
-
1
-
2
The Francisella Type VI Secretion System oleh Daniel L. Clemens, Bai-Yu Lee, Marcus A. Horwitz
Diterbitkan 2018-04-01
Artikel -
3
-
4
Listeria-Vectored Multiantigenic Tuberculosis Vaccine Enhances Protective Immunity against Aerosol Challenge with Virulent Mycobacterium tuberculosis in BCG-Immunized C57BL/6 and B... oleh Qingmei Jia, Saša Masleša-Galić, Susana Nava, Marcus A. Horwitz
Diterbitkan 2022-06-01
Artikel -
5
-
6
LVS ΔcapB-vectored multiantigenic melioidosis vaccines protect against lethal respiratory Burkholderia pseudomallei challenge in highly sensitive BALB/c mice oleh Michael V. Tullius, Richard A. Bowen, Peter S. Back, Saša Masleša-Galić, Susana Nava, Marcus A. Horwitz
Diterbitkan 2024-04-01
Artikel -
7
Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia oleh Qingmei Jia, Richard Bowen, Barbara Jane Dillon, Saša Masleša-Galić, Brennan T. Chang, Austin C. Kaidi, Marcus A. Horwitz
Diterbitkan 2018-05-01
Artikel -
8
Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19-like disease in hamsters oleh Qingmei Jia, Helle Bielefeldt-Ohmann, Rachel M. Maison, Saša Masleša-Galić, Sarah K. Cooper, Richard A. Bowen, Marcus A. Horwitz
Diterbitkan 2021-03-01
Artikel -
9
Ultra-rapid near universal TB drug regimen identified via parabolic response surface platform cures mice of both conventional and high susceptibility. oleh Bai-Yu Lee, Daniel L Clemens, Aleidy Silva, Barbara Jane Dillon, Saša Masleša-Galić, Susana Nava, Chih-Ming Ho, Marcus A Horwitz
Diterbitkan 2018-01-01
Artikel -
10
Drug regimens identified and optimized by output-driven platform markedly reduce tuberculosis treatment time oleh Bai-Yu Lee, Daniel L. Clemens, Aleidy Silva, Barbara Jane Dillon, Saša Masleša-Galić, Susana Nava, Xianting Ding, Chih-Ming Ho, Marcus A. Horwitz
Diterbitkan 2017-01-01
Artikel -
11
Artificial intelligence enabled parabolic response surface platform identifies ultra-rapid near-universal TB drug treatment regimens comprising approved drugs. oleh Daniel L Clemens, Bai-Yu Lee, Aleidy Silva, Barbara Jane Dillon, Saša Masleša-Galić, Susana Nava, Xianting Ding, Chih-Ming Ho, Marcus A Horwitz
Diterbitkan 2019-01-01
Artikel -
12
Efficacy and safety of an innovative short-course regimen containing clofazimine for treatment of drug-susceptible tuberculosis: a clinical trial oleh Xubin Zheng, Xuwei Gui, Lan Yao, Jun Ma, Yifan He, Hai Lou, Jin Gu, Ruoyan Ying, Liping Chen, Qin Sun, Yidian Liu, Chih-Ming Ho, Bai-Yu Lee, Daniel L. Clemens, Marcus A. Horwitz, Xianting Ding, Xiaohui Hao, Hua Yang, Wei Sha
Diterbitkan 2023-12-01
Artikel -
13
Type I and Type II Interferon Coordinately Regulate Suppressive Dendritic Cell Fate and Function during Viral Persistence. oleh Cameron R Cunningham, Ameya Champhekar, Michael V Tullius, Barbara Jane Dillon, Anjie Zhen, Justin Rafael de la Fuente, Jonathan Herskovitz, Heidi Elsaesser, Laura M Snell, Elizabeth B Wilson, Juan Carlos de la Torre, Scott G Kitchen, Marcus A Horwitz, Steven J Bensinger, Stephen T Smale, David G Brooks
Diterbitkan 2016-01-01
Artikel -
14
The rLVS ΔcapB/iglABC vaccine provides potent protection in Fischer rats against inhalational tularemia caused by various virulent Francisella tularensis strains oleh Kevin D. Mlynek, Curtis R. Cline, Sergei S. Biryukov, Ronald G. Toothman, Beth A. Bachert, Christopher P. Klimko, Jennifer L. Shoe, Melissa Hunter, Zander M. Hedrick, Jennifer L. Dankmeyer, Sherry Mou, David P. Fetterer, Ju Qiu, Eric D. Lee, Christopher K. Cote, Qingmei Jia, Marcus A. Horwitz, Joel A. Bozue
Diterbitkan 2023-12-01
Artikel